Palvella Therapeutics (PVLA) Profit After Tax (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.01% |
| Dec 31, 2025 | -12.07% |
| Sep 30, 2025 | -19.79% |
| Jun 30, 2025 | -15.50% |
| Mar 31, 2025 | -107.54% |
| Dec 31, 2024 | 41.68% |
| Sep 30, 2024 | -62.39% |
| Jun 30, 2024 | -64.51% |
| Mar 31, 2024 | -106.56% |
| Dec 31, 2023 | 459.47% |
| Sep 30, 2023 | -370.42% |
| Jun 30, 2023 | 130.12% |
| Sep 30, 2022 | 5.48% |
| Jun 30, 2022 | -101.96% |
| Mar 31, 2022 | 46.53% |
| Dec 31, 2021 | 42.32% |
| Sep 30, 2021 | -6.68% |
| Jun 30, 2021 | -269.05% |
| Mar 31, 2021 | 70.83% |
| Dec 31, 2020 | -0.82% |
| Sep 30, 2020 | -188.55% |
| Jun 30, 2020 | -37.50% |
| Mar 31, 2020 | -366.93% |
| Dec 31, 2019 | 70.25% |
| Sep 30, 2019 | 77.96% |
| Jun 30, 2019 | -13.63% |
| Mar 31, 2019 | 11.42% |
| Dec 31, 2018 | -89.86% |
| Sep 30, 2018 | -2,931.03% |
| Jun 30, 2018 | 97.67% |
| Mar 31, 2018 | -216.33% |
| Dec 31, 2017 | 206.12% |
| Sep 30, 2017 | 30.00% |
| Jun 30, 2017 | -26.16% |
| Mar 31, 2017 | -21.89% |
| Dec 31, 2016 | -5.85% |
| Sep 30, 2016 | -5.32% |
| Jun 30, 2016 | -41.39% |
| Mar 31, 2016 | -43.40% |
| Dec 31, 2015 | 26.02% |
| Sep 30, 2015 | -11.11% |
| Jun 30, 2015 | 4.72% |
| Sep 30, 2014 | 29.83% |
| Jun 30, 2014 | -269.49% |
| Mar 31, 2014 | -35,382.48% |
| Dec 31, 2013 | 61.85% |
| Sep 30, 2013 | -2,002.92% |